A Phase 1 Open-label, Multicenter Study of MK-6837 as Monotherapy and Combination Therapy in Participants with Advanced/Metastatic Solid Tumors

  • Voskoboynik, Mark (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date30/08/24 → 29/08/26

Keywords

  • Clinical Trials
  • MK-6837-001